Cargando…

Netrin-1 is a novel regulator of vascular endothelial function in diabetes

BACKGROUND: Netrin-1, a secreted laminin-like protein identified as an axon guidance molecule, has been shown to be of critical importance in the cardiovascular system. Recent studies have revealed pro-angiogenic, anti-apoptotic and anti-inflammatory properties of netrin-1 as well as cardioprotectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Toque, Haroldo A., Fernandez-Flores, Aracely, Mohamed, Riyaz, Caldwell, Ruth B., Ramesh, Ganesan, Caldwell, R. William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653335/
https://www.ncbi.nlm.nih.gov/pubmed/29059224
http://dx.doi.org/10.1371/journal.pone.0186734
_version_ 1783273214075469824
author Toque, Haroldo A.
Fernandez-Flores, Aracely
Mohamed, Riyaz
Caldwell, Ruth B.
Ramesh, Ganesan
Caldwell, R. William
author_facet Toque, Haroldo A.
Fernandez-Flores, Aracely
Mohamed, Riyaz
Caldwell, Ruth B.
Ramesh, Ganesan
Caldwell, R. William
author_sort Toque, Haroldo A.
collection PubMed
description BACKGROUND: Netrin-1, a secreted laminin-like protein identified as an axon guidance molecule, has been shown to be of critical importance in the cardiovascular system. Recent studies have revealed pro-angiogenic, anti-apoptotic and anti-inflammatory properties of netrin-1 as well as cardioprotective actions against myocardial injury in diabetic mice. AIM: To examine the role of netrin-1 in diabetes-and high glucose (HG)-induced vascular endothelial dysfunction (VED) using netrin-1 transgenic mice (Tg3) and cultured bovine aortic endothelial cells (BAEC). MAIN OUTCOME: Overexpression of netrin-1 prevented diabetes-induced VED in aorta from diabetic mice and netrin-1 treatment attenuated HG-induced impairment of nitric oxide synthase (NOS) function in BAECs. METHODS AND RESULTS: Experiments were performed in Tg3 and littermate control (WT) mice rendered diabetic with streptozotocin (STZ) and in BAECs treated with HG (25 mmol/L). Levels of netrin-1 and its receptor DCC, markers of inflammation and apoptosis and vascular function were assessed in aortas from diabetic and non-diabetic Tg3 and WT mice. Vascular netrin-1 in WT mice was reduced under diabetic conditions. Aortas from non-diabetic Tg3 and WT mice showed similar maximum endothelium-dependent relaxation (MEDR) (83% and 87%, respectively). MEDR was markedly impaired in aorta from diabetic WT mice (51%). This effect was significantly blunted in Tg3 diabetic aortas (70%). Improved vascular relaxation in Tg3 diabetic mice was associated with increased levels of phospho-ERK1/2 and reduced levels of oxidant stress, NFκB, COX-2, p16(INK4A), cleaved caspase-3 and p16 and p53 mRNA. Netrin-1 treatment prevented the HG-induced decrease in NO production and elevation of oxidative stress and apoptosis in BAECs. CONCLUSIONS: Diabetes decreases aortic levels of netrin-1. However, overexpression of netrin-1 attenuates diabetes-induced VED and limits the reduction of NO levels, while increasing expression of p-ERK1/2, and suppressing oxidative stress and inflammatory and apoptotic processes. Enhancement of netrin-1 function may be a useful therapeutic means for preventing vascular dysfunction in diabetes.
format Online
Article
Text
id pubmed-5653335
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56533352017-11-08 Netrin-1 is a novel regulator of vascular endothelial function in diabetes Toque, Haroldo A. Fernandez-Flores, Aracely Mohamed, Riyaz Caldwell, Ruth B. Ramesh, Ganesan Caldwell, R. William PLoS One Research Article BACKGROUND: Netrin-1, a secreted laminin-like protein identified as an axon guidance molecule, has been shown to be of critical importance in the cardiovascular system. Recent studies have revealed pro-angiogenic, anti-apoptotic and anti-inflammatory properties of netrin-1 as well as cardioprotective actions against myocardial injury in diabetic mice. AIM: To examine the role of netrin-1 in diabetes-and high glucose (HG)-induced vascular endothelial dysfunction (VED) using netrin-1 transgenic mice (Tg3) and cultured bovine aortic endothelial cells (BAEC). MAIN OUTCOME: Overexpression of netrin-1 prevented diabetes-induced VED in aorta from diabetic mice and netrin-1 treatment attenuated HG-induced impairment of nitric oxide synthase (NOS) function in BAECs. METHODS AND RESULTS: Experiments were performed in Tg3 and littermate control (WT) mice rendered diabetic with streptozotocin (STZ) and in BAECs treated with HG (25 mmol/L). Levels of netrin-1 and its receptor DCC, markers of inflammation and apoptosis and vascular function were assessed in aortas from diabetic and non-diabetic Tg3 and WT mice. Vascular netrin-1 in WT mice was reduced under diabetic conditions. Aortas from non-diabetic Tg3 and WT mice showed similar maximum endothelium-dependent relaxation (MEDR) (83% and 87%, respectively). MEDR was markedly impaired in aorta from diabetic WT mice (51%). This effect was significantly blunted in Tg3 diabetic aortas (70%). Improved vascular relaxation in Tg3 diabetic mice was associated with increased levels of phospho-ERK1/2 and reduced levels of oxidant stress, NFκB, COX-2, p16(INK4A), cleaved caspase-3 and p16 and p53 mRNA. Netrin-1 treatment prevented the HG-induced decrease in NO production and elevation of oxidative stress and apoptosis in BAECs. CONCLUSIONS: Diabetes decreases aortic levels of netrin-1. However, overexpression of netrin-1 attenuates diabetes-induced VED and limits the reduction of NO levels, while increasing expression of p-ERK1/2, and suppressing oxidative stress and inflammatory and apoptotic processes. Enhancement of netrin-1 function may be a useful therapeutic means for preventing vascular dysfunction in diabetes. Public Library of Science 2017-10-23 /pmc/articles/PMC5653335/ /pubmed/29059224 http://dx.doi.org/10.1371/journal.pone.0186734 Text en © 2017 Toque et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Toque, Haroldo A.
Fernandez-Flores, Aracely
Mohamed, Riyaz
Caldwell, Ruth B.
Ramesh, Ganesan
Caldwell, R. William
Netrin-1 is a novel regulator of vascular endothelial function in diabetes
title Netrin-1 is a novel regulator of vascular endothelial function in diabetes
title_full Netrin-1 is a novel regulator of vascular endothelial function in diabetes
title_fullStr Netrin-1 is a novel regulator of vascular endothelial function in diabetes
title_full_unstemmed Netrin-1 is a novel regulator of vascular endothelial function in diabetes
title_short Netrin-1 is a novel regulator of vascular endothelial function in diabetes
title_sort netrin-1 is a novel regulator of vascular endothelial function in diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653335/
https://www.ncbi.nlm.nih.gov/pubmed/29059224
http://dx.doi.org/10.1371/journal.pone.0186734
work_keys_str_mv AT toqueharoldoa netrin1isanovelregulatorofvascularendothelialfunctionindiabetes
AT fernandezfloresaracely netrin1isanovelregulatorofvascularendothelialfunctionindiabetes
AT mohamedriyaz netrin1isanovelregulatorofvascularendothelialfunctionindiabetes
AT caldwellruthb netrin1isanovelregulatorofvascularendothelialfunctionindiabetes
AT rameshganesan netrin1isanovelregulatorofvascularendothelialfunctionindiabetes
AT caldwellrwilliam netrin1isanovelregulatorofvascularendothelialfunctionindiabetes